Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TCRX
#3154
TScan Therapeutics, Inc. Common Stock
1.0
6
-3.64%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-3.64%
Mudança mensal
-4.50%
Mudança em 6 meses
-43.32%
Mudança anual
-48.29%
Fechamento anterior
1.1
0
Open
1.0
6
Bid
Ask
Low
1.0
6
High
1.0
6
Volume
6
Mercados
Ações
Cuidados de saúde
TCRX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
49.09 M
52.31 M
52.31 M
52.47 M
52.47 M
—
Valuation ratios
Enterprise value
642.94 M
324.42 M
74.28 M
71.26 M
132.55 M
602.51 M
Price to earnings ratio
-9.4
-2.67
-1.28
-1.34
-1.64
-6.93
Price to sales ratio
38.47
120.9
38.08
26.26
27.69
212.92
Price to cash flow ratio
4.38
3.07
1.38
1.41
1.75
7.61
Price to book ratio
0.64
1.41
0.17
0.21
0.29
2.08
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.1
0.1
0.12
0.14
0.46
Return on equity %
0.13
0.15
0.16
0.21
0.25
0.77
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
3 109.82
5 520.6
1 669.74
1 256.6
1 475.59
9 922.53
EBITDA margin %
—
—
—
—
—
—
Net margin %
2 849.09
5 384.81
1 571.95
1 201.3
1 422.14
9 580.2
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.56
8.14
8.55
7.06
6.44
30.19
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.01
0.01
0.01
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.09
0.09
0.1
0.11
0.12
0.41
Long term debt to total equity ratio
0.13
0.13
0.15
0.18
0.23
0.69
Per share metrics
Operating cash flow per share
0.24
0.24
0.29
0.26
0.25
1.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.28
2.59
1.94
1.68
1.42
7.63
Net current asset value per share
2.31
2.61
1.97
1.7
1.45
7.73
Tangible book value per share
1.93
2.15
1.62
1.36
1.11
6.24
Working capital per share
2.07
2.29
1.74
1.46
1.22
6.72
Book value per share
1.93
2.15
1.62
1.36
1.11
6.24
Notícias
TScan completes enrollment in trial cohort, receives FDA clearance
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue Estimates
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Beats Revenue Estimates
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains?
Roivant Sciences Ltd. (ROIV) Reports Q3 Loss, Misses Revenue Estimates
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Ações da Tscan Therapeutics mantêm classificação neutra da BTIG após evento ASH
Tscan Therapeutics stock holds Neutral rating at BTIG after ASH event
TScan to host KOL event discussing updated ALLOHA trial data
Morgan Stanley rebaixa ações da Tscan Therapeutics devido a atrasos nos ensaios
Morgan Stanley downgrades Tscan Therapeutics stock on delayed trials
Lucro da Tscan Therapeutics superou projeções por $0,06; receita supera estimativas